Results 181 to 190 of about 2,198,135 (358)

Cross-neutralization of SARS-CoV-2 by a human monoclonal SARS-CoV antibody

open access: yesNature, 2020
D. Pinto   +24 more
semanticscholar   +1 more source

Nanocarrier‐Based Targeting of Pattern Recognition Receptors as an Innovative Strategy for Enhancing Sepsis Therapy

open access: yesAdvanced Healthcare Materials, EarlyView.
This review highlights recent progress in nanocarriers targeting pattern recognition receptors (PRRs), including Toll‐like and NOD‐like receptors, for enhancing the treatment of bacterial sepsis and related complications. These nanomedicines deliver antibiotics and anti‐inflammatory agents while modulating immune responses.
Eman A. Ismail   +3 more
wiley   +1 more source

Generation of Novel Monoclonal Antibodies Recognizing Rabbit CD34 Antigen. [PDF]

open access: yesBiomolecules
Vašíček J   +9 more
europepmc   +1 more source

Differential Phase Contrast Imaging to Predict MSC Immune Function

open access: yesAdvanced Healthcare Materials, EarlyView.
This work employs quantitative differential phase contrast (qDPC) imaging technique to non‐invasively extract morphological features from live Mesenchymal Stromal Cells (MSCs) for single cell prediction on cell immunomodulatory capacity. This work establishes a foundation for scalable, non‐destructive monitoring of MSCs immunomodulatory capacity ...
Kejie Rui   +5 more
wiley   +1 more source

Rational Design of Envelope Identifies Broadly Neutralizing Human Monoclonal Antibodies to HIV-1

open access: yesScience, 2010
Xueling Wu   +23 more
semanticscholar   +1 more source

Murine monoclonal antibody to secretory component.

open access: bronze, 1989
Kaoru Kusama   +6 more
openalex   +2 more sources

Analysis of T cell activation requirements with the use of alloantigens or an anti-clonotypic monoclonal antibody. [PDF]

open access: bronze, 1986
Christine Hua   +4 more
openalex   +1 more source

Self‐Assembling Multi‐Antigen T Cell Hybridizers for Precision Immunotherapy of Multiple Myeloma

open access: yesAdvanced Healthcare Materials, EarlyView.
A novel modular T‐cell engager platform, MATCH, is developed for personalized multiple myeloma therapy. MATCH uses complementary oligonucleotide‐linked Fab’ fragments to enable flexible targeting of MM antigens and controlled T‐cell activation. The system shows potent, antigen‐specific cytotoxicity in vitro and in vivo, highlighting its potential for ...
Shannuo Li   +8 more
wiley   +1 more source

Home - About - Disclaimer - Privacy